Flufenamic acid and indomethacin in rheumatoid arthritis.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003967:Diarrhea / Q000139:chemically induced; D004063:Digestion / Q000187:drug effects; D005260:Female; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006261:Headache / Q000139:chemically induced; D006452:Hemoglobinometry; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D010919:Placebos; D014012:Tinnitus / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010919:Placebos; D062367:ortho-Aminobenzoates; D005461:Fluorine; D005439:Flufenamic Acid; D007213:Indomethacin